https://www.selleckchem.com/pr....oducts/picrotoxin.ht
Older patients (65+) with mild cognitive impairment (MCI) receive less guideline-concordant care for cardiovascular disease (CVD) and other conditions than patients with normal cognition (NC). One potential explanation is that patients with MCI want less treatment than patients with NC; however, the treatment preferences of patients with MCI have not been studied. To determine whether patients with MCI have different treatment preferences than patients with NC. Cross-sectional survey conducted at two academic medical centers from Feb
Like
Comment
Share
